Ulta Beauty Crushes Expectations for Q2

Photo of Chris Lange
By Chris Lange Published
Ulta Beauty Crushes Expectations for Q2

© jeepersmedia / Flickr

When Ulta Beauty Inc. (NASDAQ: ULTA | ULTA Price Prediction) released its most recent quarterly results after the markets closed on Thursday, the firm said that it had $0.73 in earnings per share (EPS) and $1.2 billion in revenue. Consensus estimates were calling for $0.06 in EPS and revenue of $1.24 billion. The fiscal second quarter of last year reportedly had EPS of $2.72 on $1.67 billion in revenue.

During the latest quarter, net sales decreased 26.3% year over year. Comparable sales, which include stores that were temporarily closed due to the COVID-19 crisis, as well as e-commerce sales, decreased 26.7%, compared with an increase of 6.2% in the second quarter of fiscal 2019. Also in the most recent quarter, transactions declined 36.2% and average ticket increased 14.9%.

Management noted that it is encouraged by the recent improvement in sales trends, but it still believes it will take time to return fully to pre-pandemic levels. Given continued disruption, new operational protocols and near-term employment and economic uncertainty, Ulta expects sales will continue to be challenged for the rest of the year.

The company withdrew guidance for the fiscal 2020 year back in March, and it will not be reinstating it anytime soon. However, the firm did give some insight. The company expects to incur between $35 million and $40 million in PPE- and COVID-19-related costs. It also anticipates capital expenditures will be between $180 million and $200 million.

[nativounit]

On the books, the company ended the second quarter with $1.2 billion in cash and cash equivalents. In the fiscal first quarter, the company drew down $800 million under its $1.0 billion credit facility.

Analysts were calling for $1.67 in EPS and $1.63 billion in revenue for the fiscal third quarter. For the 2021 fiscal year, they expect $4.16 in EPS and $6.4 billion in revenue.

Ulta Beauty stock traded about 12% on Friday to $251.07, in a 52-week range of $124.05 to $304.65. The consensus price target is $262.59.

[recirclink id=731643][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

ENPH Vol: 8,850,799
RL Vol: 972,678
IBM
IBM Vol: 14,018,519
FSLR Vol: 2,120,569
STX Vol: 1,950,673

Top Losing Stocks

INTU Vol: 15,389,313
CTRA Vol: 73,319,495
WMT Vol: 32,755,088
DE Vol: 1,668,801
CMI Vol: 676,340